The Health-Promoting Role of Pears in Men and Women With Metabolic Syndrome
Primary Purpose
Metabolic Syndrome
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Pear
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Metabolic Syndrome
Eligibility Criteria
Inclusion Criteria:
- Men and women
- Aged 45-65 years old
- Three of the following five features at the screening visit:
- Waist circumference of ≥ 40 inches for men and 35 inches for women
- Serum triglycerides ≥ 150 mg/dL
- Serum high density lipoprotein cholesterol levels < 40 mg/dL for men and <50 mg/dL for women
- Blood pressure ≥ 130/85 mm Hg
- Fasting blood glucose level ≥ 110 mg/dL
Exclusion Criteria:
- Taking hypoglycemic, antihypertensive or cholesterol-lowering medications
- Diagnosed cardiovascular disease
- Uncontrolled hypertension (≥ 160/100 mmHg)
- Diabetes mellitus
- Other active chronic diseases such as cancer, asthma, glaucoma, thyroid, kidney, liver and pancreatic disease
- Participating in a weight loss program
- Heavy smokers (> 20 cigarettes per day)
- Heavy drinkers (> 12 alcoholic drinks per week)
Sites / Locations
- Department of Nutrition, Food and Exercise Sciences, Center for Advancing Exercise and Nutrition Research on Aging, Florida State University
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Experimental
Arm Label
Placebo
Pear
Arm Description
12 weeks of consuming 50 g pear-flavored placebo powder mixed with 480 ml per day (1/2 in the morning and 1/2 in the evening at least 6-8 hours apart).
12 weeks of consuming 2 medium-sized pears per day (1 in the morning and 1 in the evening at least 6-8 hours apart).
Outcomes
Primary Outcome Measures
Blood Pressure
By measuring brachial blood pressure at rest.
Secondary Outcome Measures
Atherogenic Markers
By measuring lipid profiles and atherogenic risk ratios.
Inflammation
By measuring markers of inflammation.
Oxidative Stress
By measuring markers of oxidative stress.
Insulin Sensitivity
By measuring fasting glucose, insulin, homeostatic model of insulin resistance, and hemoglobin A1C.
Body Composition
By measuring fat mass and fat-free mass using dual-energy X-ray absorptiometry and anthropometrics.
Gastrointestinal Health
By using a validated Seven-Day Bowel Movement Questionnaire and serum levels of short-chain fatty acids.
Full Information
NCT ID
NCT02228837
First Posted
August 27, 2014
Last Updated
December 6, 2016
Sponsor
Florida State University
Collaborators
Pear Bureau Northwest, Washington Tree Fruit Research Commission, USDA Beltsville Human Nutrition Research Center
1. Study Identification
Unique Protocol Identification Number
NCT02228837
Brief Title
The Health-Promoting Role of Pears in Men and Women With Metabolic Syndrome
Official Title
The Health-Promoting Role of Pears in Men and Women With Metabolic Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
December 2016
Overall Recruitment Status
Completed
Study Start Date
August 2014 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
May 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Florida State University
Collaborators
Pear Bureau Northwest, Washington Tree Fruit Research Commission, USDA Beltsville Human Nutrition Research Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The hypothesis of this study is that the daily consumption of 2 medium-sized pears for twelve weeks will improve blood pressure, lipid profiles, glycemic control and insulin resistance, inflammatory and oxidative status in men and women with metabolic syndrome. 50 men and women between the ages of 45 and 65 who have three of the five features of metabolic syndrome as defined by the Adult Treatment Panel III will be included in the study. After a two-week run-in phase, eligible men and women will be randomly assigned to one of two treatment groups: 1) 2 medium-sized pears; or 2) 50 g placebo powder daily for twelve weeks. After an initial telephone screening, all participants will be requested to report to the study site for their first visit. On the first visit (screening), participants will be provided with verbal and written explanation of the project. They will then be asked to sign an informed consent form, followed by measuring waist circumference, resting brachial blood pressure, fasting serum triglycerides, high density lipoprotein cholesterol, and glucose levels to confirm metabolic syndrome. Baseline assessments will be performed for medical history, medication use, dietary intake, and physical activity. Qualified participants will be scheduled for their second visit two weeks later (actual baseline data collection) and randomly assigned to their treatment group. On the second (baseline) visit between the hours of 6-11 A.M., blood pressure will be measured followed by blood draw and urine collection. Anthropometrics and body composition will be measured. Questionnaires regarding diet, physical activity, and gastrointestinal health will be performed. Participants will be provided with their assigned treatment and will receive standard instructions on how to fill out daily diaries for their treatment. All assessments will be repeated at 6- (third visit), and 12-week (final visit) intervals. All assessments and information will be collected after an overnight fast and 12 hours after the abstinence of caffeine and/or 24 hours after the last bout of moderate to heavy physical activity. After the initial 12 weeks, participants will undergo a 4-week washout period in which they will not consume either the intervention or the placebo. After the 4-week washout period, participants will crossover into the other group to receive either the intervention or placebo.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metabolic Syndrome
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
12 weeks of consuming 50 g pear-flavored placebo powder mixed with 480 ml per day (1/2 in the morning and 1/2 in the evening at least 6-8 hours apart).
Arm Title
Pear
Arm Type
Experimental
Arm Description
12 weeks of consuming 2 medium-sized pears per day (1 in the morning and 1 in the evening at least 6-8 hours apart).
Intervention Type
Dietary Supplement
Intervention Name(s)
Pear
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Primary Outcome Measure Information:
Title
Blood Pressure
Description
By measuring brachial blood pressure at rest.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Atherogenic Markers
Description
By measuring lipid profiles and atherogenic risk ratios.
Time Frame
12 weeks
Title
Inflammation
Description
By measuring markers of inflammation.
Time Frame
12 weeks
Title
Oxidative Stress
Description
By measuring markers of oxidative stress.
Time Frame
12 weeks
Title
Insulin Sensitivity
Description
By measuring fasting glucose, insulin, homeostatic model of insulin resistance, and hemoglobin A1C.
Time Frame
12 weeks
Title
Body Composition
Description
By measuring fat mass and fat-free mass using dual-energy X-ray absorptiometry and anthropometrics.
Time Frame
12 weeks
Title
Gastrointestinal Health
Description
By using a validated Seven-Day Bowel Movement Questionnaire and serum levels of short-chain fatty acids.
Time Frame
12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Men and women
Aged 45-65 years old
Three of the following five features at the screening visit:
Waist circumference of ≥ 40 inches for men and 35 inches for women
Serum triglycerides ≥ 150 mg/dL
Serum high density lipoprotein cholesterol levels < 40 mg/dL for men and <50 mg/dL for women
Blood pressure ≥ 130/85 mm Hg
Fasting blood glucose level ≥ 110 mg/dL
Exclusion Criteria:
Taking hypoglycemic, antihypertensive or cholesterol-lowering medications
Diagnosed cardiovascular disease
Uncontrolled hypertension (≥ 160/100 mmHg)
Diabetes mellitus
Other active chronic diseases such as cancer, asthma, glaucoma, thyroid, kidney, liver and pancreatic disease
Participating in a weight loss program
Heavy smokers (> 20 cigarettes per day)
Heavy drinkers (> 12 alcoholic drinks per week)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bahram H. Arjmandi, PhD, RD
Organizational Affiliation
Department of Nutrition, Food and Exercise Sciences, Center for Advancing Exercise and Nutrition Research on Aging, Florida State University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Sarah A. Johnson, PhD, RDN
Organizational Affiliation
Department of Food Science and Human Nutrition, Colorado State University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Nutrition, Food and Exercise Sciences, Center for Advancing Exercise and Nutrition Research on Aging, Florida State University
City
Tallahassee
State/Province
Florida
ZIP/Postal Code
32306
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
30720034
Citation
Navaei N , Pourafshar S , Akhavan NS , Litwin NS , Foley EM , George KS , Hartley SC , Elam ML , Rao S , Arjmandi BH , Johnson SA . Influence of daily fresh pear consumption on biomarkers of cardiometabolic health in middle-aged/older adults with metabolic syndrome: a randomized controlled trial. Food Funct. 2019 Feb 20;10(2):1062-1072. doi: 10.1039/c8fo01890a.
Results Reference
derived
Learn more about this trial
The Health-Promoting Role of Pears in Men and Women With Metabolic Syndrome
We'll reach out to this number within 24 hrs